CRWD vs UNH: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and UnitedHealth Group Incorporated β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-24.
CrowdStrike Holdings, Inc. Β· Technology
$436.32
+34.6% upside to fair value
Grade B
VS
UnitedHealth Group Incorporated Β· Healthcare
$353.52
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
UNH has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD UNH
Current Price $436.32 $353.52
Fair Value Estimate $587.16 $512.60
Upside to Fair Value +34.6% +45.0%
Market Cap $110.7B $320.9B
Forward P/E -601.6x 26.7x
EV / EBITDA 951.5x 16.1x
Price / Sales 23.0x 0.7x
Price / FCF 89.3x 16.3x
Revenue Growth YoY +23.3% +2.0%
Gross Margin 74.9% 18.8%
Operating Margin -5.4% 4.2%
Return on Equity -4.7% 12.4%
Dividend Yield 0% 0%
FCF Yield 1.12% 6.13%
Analyst Consensus Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-based endpoint protection and threat intelligence, with a dominant subscription revenue model accounting for over 95% of total revenue. The business quality is medium due to strong revenue growth of 23.3% in the most recent quarter and a robust earnings growth of 141.9% in the same period, supported by a high gros…
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
Metric CRWD UNH
Zone Low $440.37 $384.45
Zone High $499.09 $435.71
In Buy Zone? Yes Yes
← CRWD Research    UNH Research β†’    All Research